About the Company
We do not have any company description for Vor Biopharma Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Vor Biopharma Inc.
VOR Stock Quote Price and Forecast | CNN
View Vor Biopharma, Inc. VOR stock quote prices, financial information, real-time forecasts, and company news from CNN.
How Many Vor Biopharma Inc. (NASDAQ:VOR) Shares Do Institutions Own?
Vor Biopharma isn't enormous, but it's not particularly small either. It has a market capitalization of US$878m, which means it would generally expect to see some institutions on the share registry.
Vor Biopharma Inc. (VOR)'s Technical Outlook is Bright After Key Golden ...
Vor Biopharma Inc. (VOR) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, VOR's 50-day simple moving average crossed above ...
Vor Biopharma: Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, between August ...
Vor Biopharma Inc. (VOR) Stock Price Today - WSJ
View the latest Vor Biopharma Inc. (VOR) stock price, news, historical charts, analyst ratings and financial information from WSJ.
What's Going On With Vor Biopharma Shares Friday?
As part of the PIPE, Vor will issue a total of 55,871,260 shares of common stock and accompanying warrants to purchase an additional 69,839,075 shares, priced at $0.99425 per share and warrants.
Can Vor Biopharma Inc. (VOR) Climb 298% to Reach the Level ... - Nasdaq
Vor Biopharma Inc. (VOR) closed the last trading session at $5.13, gaining 4.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by ...
H.C. Wainwright Upgrades Vor Biopharma (VOR) to a Buy, Sets a $3 Price ...
Vor Biopharma Inc. (NASDAQ:VOR) is one of the hot penny stocks to invest in now. In a report released on June 30, Swayampakula Ramakanth from H.C. Wainwright upgraded Vor Biopharma Inc.
Vor Biopharma (VOR) Receives a Buy from Wedbush - Markets Insider
Wedbush analyst David Nierengarten maintained a Buy rating on Vor Biopharma (VOR – Research Report) today and set a price target of $11.00. The company’s shares closed yesterday at $1.81 ...
Vor Biopharma prices upsized IPO at the top of the expected range ...
Vor Biopharma Inc. , the Massachusetts-based cell therapy company focused on cancer treatments, said Friday that its upsized initial public offering priced at the top of the expected range to ...
Vor Biopharma Inc. (VOR)'s Technical Outlook is Bright After ... - Nasdaq
Vor Biopharma Inc. (VOR) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, VOR's 50-day simple moving average crossed above ...
Similar Companies
Loading the latest forecasts...